1 |
Vogler S, Zimmermann N. The potential of generics policies: more room for exploitation: PPRI conference report. Generics Biosimilars Initiat J 2012;1(3-4):146-149. DOI: https://doi.org/10.5639/gabij.2012.0103-4.030.
DOI
|
2 |
European Generic Medicines Association. How to increase patient access to generic medicines in European healthcare systems. Brussels: European Generic Medicines Association; 2009.
|
3 |
Organization for Economic Cooperation and Development. OECD homepage [Internet]. Paris: Organization for Economic Cooperation and Development [cited 2019 Dec 20]. Available from: https://www.oecd.org/.
|
4 |
Organization for Economic Cooperation and Development. OECD health data: pharmaceutical spending [Internet]. Paris: Organization for Economic Cooperation and Development; 2019 [cited 2019 Dec 20]. Available from: https://data.oecd.org/healthres/pharmaceutical-spending.
|
5 |
World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: Collaborating Centre for Drug Statistics Methodology; 2019.
|
6 |
Choi JS, Chae SE, Park GC, Cho YH, Cho SB. Health care utilization in 2018. Wonju: Health Insurance Review and Assessment Service; 2019.
|
7 |
Organization for Economic Cooperation and Development. Health at a glance 2019: OECD indicators. Paris: Organization for Economic Cooperation and Development; 2019.
|
8 |
Jung HS. Korean pharmaceutical expenditure according to OECD's system of health accounts. Korea J Health Policy Adm 2013;13(3):48-65. DOI: https://doi.org/10.4332/kjhpa.2003.13.4.48.
|
9 |
Jeong HS, Shin JW. 2015 National Health Accounts and current health expenditures in Korea. Health Policy Manag 2017;27(3):199-210. DOI: https://doi.org/10.4332/KJHPA.2017.27.3.199.
DOI
|
10 |
Jeong HS, Shin JW, Moon SW, Choi JS, Kim H. 2018 Current health expenditures and National Health Accounts in Korea. Health Policy Manag 2019;29(2):206-219. DOI: https://doi.org/10.4332/KJHPA.2019.29.2.206.
DOI
|
11 |
Health Insurance Review and Assessment Service. Statistics of reimbursement medication claims. Wonju: Health Insurance Review and Assessment Service; 2018.
|
12 |
Health Insurance Review and Assessment Service. Statistics of pharmaceutical supply. Wonju: Health Insurance Review and Assessment Service; 2018.
|
13 |
Health Insurance Review and Assessment Service. Report of pharmaceutical prescribing evaluation result. Wonju: Health Insurance Review and Assessment Service; 2018.
|
14 |
World Health Organization. Rational use of medicines [Internet]. Geneva: World Health Organization; 2007 [cited 2019 Dec 20]. Available from: http://who.int/medicines/areas/rational_use/en/.
|
15 |
World Health Organization. The pursuit of responsible use of medicines: sharing and learning from country experiences: technical report prepared for the Ministers Summit on the benefits of responsible use of medicines: setting policies for better and cost-effective health care. Geneva: World Health Organization; 2012.
|
16 |
Chapman S, Durieux P, Walley T. Good prescribing practice. In: Mossialos E, Mrazek MF, Walley T, editors. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Maidenhead: Open University Press; 2004. pp. 144-157.
|
17 |
Boston Consulting Group. Ensuring cost-effective access to innovative pharmaceuticals: do market interventions work? Boston (MA): The Boston Consulting Group; 1999.
|
18 |
Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res 2010;10(6):707-722. DOI: https://doi.org/10.1586/erp.10.72.
DOI
|
19 |
Vogler S. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries: an overview. Generics Biosimilars Initiat J 2012;1(2):93-100. DOI: https://doi.org/10.5639/gabij.2012.0102.020.
DOI
|
20 |
Vogler S, Zimmermann N, Leopold C, de Joncheere K. Pharmaceutical policies in European countries in response to the global financial crisis. South Med Rev 2011;4(2):69-79. DOI: https://doi.org/10.5655/smr.v4i2.1004.
DOI
|